Literature DB >> 16740880

Update of newborn screening and therapy for congenital hypothyroidism.

Susan R Rose, Rosalind S Brown, Thomas Foley, Paul B Kaplowitz, Celia I Kaye, Sumana Sundararajan, Surendra K Varma.   

Abstract

Unrecognized congenital hypothyroidism leads to mental retardation. Newborn screening and thyroid therapy started within 2 weeks of age can normalize cognitive development. The primary thyroid-stimulating hormone screening has become standard in many parts of the world. However, newborn thyroid screening is not yet universal in some countries. Initial dosage of 10 to 15 microg/kg levothyroxine is recommended. The goals of thyroid hormone therapy should be to maintain frequent evaluations of total thyroxine or free thyroxine in the upper half of the reference range during the first 3 years of life and to normalize the serum thyroid-stimulating hormone concentration to ensure optimal thyroid hormone dosage and compliance. Improvements in screening and therapy have led to improved developmental outcomes in adults with congenital hypothyroidism who are now in their 20s and 30s. Thyroid hormone regimens used today are more aggressive in targeting early correction of thyroid-stimulating hormone than were those used 20 or even 10 years ago. Thus, newborn infants with congenital hypothyroidism today may have an even better intellectual and neurologic prognosis. Efforts are ongoing to establish the optimal therapy that leads to maximum potential for normal development for infants with congenital hypothyroidism. Remaining controversy centers on infants whose abnormality in neonatal thyroid function is transient or mild and on optimal care of very low birth weight or preterm infants. Of note, thyroid-stimulating hormone is not elevated in central hypothyroidism. An algorithm is proposed for diagnosis and management. Physicians must not relinquish their clinical judgment and experience in the face of normal newborn thyroid test results. Hypothyroidism can be acquired after the newborn screening. When clinical symptoms and signs suggest hypothyroidism, regardless of newborn screening results, serum free thyroxine and thyroid-stimulating hormone determinations should be performed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740880     DOI: 10.1542/peds.2006-0915

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  180 in total

1.  Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening.

Authors:  Xiao-Xiao Chen; Yu-Feng Qin; Xue-Lian Zhou; Ru-Lai Yang; Yu-Hua Shi; Hua-Qing Mao; Yi-Ping Qu; Xu Wang; Zheng-Yan Zhao
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

Review 3.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

4.  Clinical, biochemical, and molecular findings in Argentinean patients with goitrous congenital hypothyroidism.

Authors:  Ana Chiesa; Carina M Rivolta; Héctor M Targovnik; Laura Gruñeiro-Papendieck
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

5.  Quality performance of newborn screening systems: strategies for improvement.

Authors:  D Webster
Journal:  J Inherit Metab Dis       Date:  2007-08-14       Impact factor: 4.982

Review 6.  Congenital hypothyroidism and the importance of universal newborn screening.

Authors:  Firas A Salim; Surendra K Varma
Journal:  Indian J Pediatr       Date:  2013-12-11       Impact factor: 1.967

7.  Hypothyroidism-associated missense mutation impairs NADPH oxidase activity and intracellular trafficking of Duox2.

Authors:  Ágnes Donkó; Stanislas Morand; Agnieszka Korzeniowska; Howard E Boudreau; Melinda Zana; László Hunyady; Miklós Geiszt; Thomas L Leto
Journal:  Free Radic Biol Med       Date:  2014-05-20       Impact factor: 7.376

8.  Primary Care Provider Management of Congenital Hypothyroidism Identified Through Newborn Screening.

Authors:  N A Rosenthal; E Bezar; S Mann; L K Bachrach; S Banerjee; M E Geffner; M Gottschalk; S K Shapira; L Hasegawa; L Feuchtbaum
Journal:  Ann Thyroid Res       Date:  2017-04-18

9.  Levothyroxine requirement in congenital hypothyroidism: a 12-year longitudinal study.

Authors:  Maurizio Delvecchio; Mariacarolina Salerno; Maria Cristina Vigone; Malgorzata Wasniewska; Pietro Pio Popolo; Rosa Lapolla; Alessandro Mussa; Giulia Maria Tronconi; Ida D'Acunzo; Raffaella Di Mase; Rosa Maria Falcone; Andrea Corrias; Filippo De Luca; Giovanna Weber; Luciano Cavallo; Maria Felicia Faienza
Journal:  Endocrine       Date:  2015-03-12       Impact factor: 3.633

10.  Neonatal screening for congenital hypothyroidism in the Federation of Bosnia and Herzegovina: eight years' experience.

Authors:  Husref Tahirović; Alma Toromanović
Journal:  Eur J Pediatr       Date:  2008-07-31       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.